QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:ACRX

AcelRx Pharmaceuticals (ACRX) News Today

$1.11
+0.02 (+1.83%)
(As of 06/8/2023 ET)
Compare
Today's Range
$1.06
▼
$1.28
50-Day Range
$0.60
▼
$1.11
52-Week Range
$0.55
▼
$7.60
Volume
437,280 shs
Average Volume
193,509 shs
Market Capitalization
$12.12 million
P/E Ratio
0.16
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
Get AcelRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter.



ACRX Media Mentions By Week

ACRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACRX
News Sentiment
▼
0.00

0.50
▲
Average
Medical
News Sentiment

ACRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACRX Articles
This Week
▼
0

1
▲
ACRX Articles
Average Week

SourceHeadline
MarketBeat logoAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Short Interest Update
americanbankingnews.com - May 31 at 3:58 AM
MarketBeat logoAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Sees Significant Drop in Short Interest
americanbankingnews.com - May 30 at 1:40 AM
MarketBeat logoAcelRx Pharmaceuticals, Inc. to Post Q2 2023 Earnings of ($0.53) Per Share, HC Wainwright Forecasts (NASDAQ:ACRX)
americanbankingnews.com - May 17 at 3:24 AM
finanznachrichten.de logoAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - May 13 at 6:18 AM
MarketBeat logoAcelRx Pharmaceuticals (NASDAQ:ACRX) Rating Lowered to Sell at StockNews.com
americanbankingnews.com - May 12 at 6:36 AM
msn.com logoRecap: AcelRx Pharmaceuticals Q1 Earnings
msn.com - May 11 at 10:29 PM
finance.yahoo.com logoAcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1
finance.yahoo.com - May 10 at 9:28 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - May 10 at 4:27 PM
MarketBeat logoAcelRx Pharmaceuticals (ACRX) to Release Earnings on Wednesday
americanbankingnews.com - May 8 at 6:46 AM
finance.yahoo.com logoEarnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q1 Earnings Expected to Decline
finance.yahoo.com - May 4 at 1:29 PM
msn.com logoAcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
msn.com - May 3 at 12:27 PM
finance.yahoo.com logoAcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023
finance.yahoo.com - April 27 at 7:24 PM
MarketBeat logoShort Interest in AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Expands By 17.5%
americanbankingnews.com - April 19 at 4:58 AM
MarketBeat logoAcelRx Pharmaceuticals (NASDAQ:ACRX) Upgraded by StockNews.com to Hold
americanbankingnews.com - April 8 at 5:54 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals
finance.yahoo.com - April 5 at 9:38 AM
finance.yahoo.com logoAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q4 2022 Earnings Call Transcript
finance.yahoo.com - April 4 at 2:20 PM
finanznachrichten.de logoAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - March 31 at 10:33 AM
markets.businessinsider.com logoAcelrx (ACRX) Receives a Hold from H.C. Wainwright
markets.businessinsider.com - March 31 at 10:33 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - March 30 at 6:44 PM
msn.com logoEarnings Outlook For AcelRx Pharmaceuticals
msn.com - March 29 at 5:42 PM
MarketBeat logoAcelRx Pharmaceuticals (ACRX) Set to Announce Earnings on Thursday
americanbankingnews.com - March 29 at 1:44 AM
finance.yahoo.com logoAcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023
finance.yahoo.com - March 21 at 5:29 PM
marketwatch.com logoAcelRx Pharmaceuticals Shares Rise Premarket on Dsuvia Sale >ACRX
marketwatch.com - March 14 at 6:55 PM
msn.com logoAcelRx adds 16% on plans to divest pain therapy
msn.com - March 14 at 6:55 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals
finance.yahoo.com - March 14 at 6:55 PM
thestreet.com logoHere's Why AcelRx Pharmaceuticals (ACRX) Stock Gained Today
thestreet.com - February 24 at 7:56 AM
forbes.com logoAcelrx Pharmaceuticals
forbes.com - January 18 at 11:46 PM
finance.yahoo.com logoAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call Transcript
finance.yahoo.com - December 29 at 8:24 AM
finance.yahoo.com logoAcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - December 27 at 1:32 PM
marketbeat.com logoThree Healthcare Penny Stocks to Watch In The New Year
marketbeat.com - December 27 at 1:00 AM
marketbeat.com logoThree Healthcare Penny Stocks to Watch In The New Year (ACRX)
marketbeat.com - December 26 at 8:37 PM
benzinga.com logoLooking Into AcelRx Pharmaceuticals's Return On Capital Employed
benzinga.com - December 26 at 1:38 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces European Peer-Reviewed Publication Supporting the Benefits of Sublingual Sufentanil Tablets For Post-Operative Pain Management in the Journal of Clinical Medicine
finance.yahoo.com - December 8 at 8:56 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
finance.yahoo.com - November 17 at 6:29 AM
markets.businessinsider.com logoAcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
markets.businessinsider.com - November 15 at 9:54 AM
finance.yahoo.com logoAcelRx to Host Third Quarter 2022 Financial Results Call and Webcast on November 14, 2022
finance.yahoo.com - November 3 at 10:19 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Presentation of a Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA at Plastic Surgery The Meeting 2022
finance.yahoo.com - October 31 at 9:54 AM
marketbeat.com logoAcelRx Pharmaceuticals (NASDAQ:ACRX) Earns Hold Rating from Analysts at StockNews.com
marketbeat.com - October 28 at 2:25 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces the European Launch of DZUVEO by its Partner, Aguettant
finance.yahoo.com - October 27 at 7:25 PM
finanznachrichten.de logoAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Announces Reverse Stock Split
finanznachrichten.de - October 26 at 11:43 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Presentation of Investigator-Initiated Trial Results Comparing AcelRx's Sufentanil Sublingual Tablet (SST) Versus Intravenous Opioids for Postoperative Pain at the ANESTHESIOLOGY® Annual Meeting 2022
finance.yahoo.com - October 26 at 11:43 AM
msn.com logoAcelRx Pharmaceuticals Announces 20-For-1 Reverse Stock Split Effective Tomorrow, Oct. 26
msn.com - October 25 at 6:38 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Reverse Stock Split
finance.yahoo.com - October 25 at 6:38 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces ANESTHESIOLOGY® 2022 Annual Meeting Presentation on DSUVIA® for Battlefield Analgesia by the Uniformed Services University of the Health Sciences
finance.yahoo.com - October 25 at 1:38 PM
seekingalpha.com logoACRX AcelRx Pharmaceuticals, Inc.
seekingalpha.com - September 23 at 12:58 PM
msn.com logoAcelRx Pharmaceuticals's Return On Capital Employed Overview
msn.com - September 6 at 11:38 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces a Second Abstract on DSUVIA® Accepted for Presentation at the ANESTHESIOLOGY® 2022 Annual Meeting
finance.yahoo.com - August 25 at 10:30 AM
seekingalpha.com logoAcelRx: The Catalogue Of Catalysts - Including A Big One That Will Do Investors Well
seekingalpha.com - August 18 at 12:22 PM
seekingalpha.com logoAcelRx Pharma stock falls ~17% premarket after Q2 results, large runup in shares
seekingalpha.com - August 12 at 12:31 PM
seekingalpha.com logoAcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 2:25 AM
Get AcelRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ACRX) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -